 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
+ \% _0 ]/ o, B3 }5 A, X
9 j# S5 x$ I7 v8 z% dEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
% P6 `# u2 ~" Z7 s/ i " [% Q- H1 d' ]+ g4 w1 G
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007
. }) G8 g+ f5 V b1 h6 N) t, B
) W( w; r/ }# d7 R
. a' D: ?1 ?' s3 a" WEDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
/ Z3 e( ?. q: S/ E G9 K/ X- U4 q9 [/ _: x2 s8 V! I7 V8 I
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM.": b( ?1 u) U! m( \; {8 X. d
8 R$ Y+ w* f2 t, H$ j+ wThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
6 J7 u$ X# S( V8 G/ F% _4 ?9 p' I7 M9 w& o3 K4 Z7 Y' y9 _
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.1 `. w, G) _" T# h7 B& E* v
3 P1 ]& W8 ^1 {! _% W) ]
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.# E! }. }3 M v6 D K7 n
9 A8 o. e8 [7 {
"As a scientist, it's one of the highlights of my CAREER," Shan said.3 a/ f1 ]* ]1 ]& A9 o4 W& R$ g
6 ^7 q: r B/ [5 s- N7 _
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."- b( c N/ [2 a9 i: k* _
1 }" V8 n: Q5 P9 T( qIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
+ M# \. d6 a% K& X6 R: ^: X
; F# Q' ?0 k9 {% t1 z3 N5 _Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.( n7 _0 g$ x* |9 a! m
, s& u" B7 z# fThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.7 N1 \, o Z) t o& E8 o* T
3 p W/ v* F" p) v
3 l5 A7 X9 J! @) E
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
